化学抵抗和瘤微环境:细胞间通信的关键作用
Bartosz Wilczyński1, Alicja Dąbrowska1, Julita Kulbacka2,3
1Faculty of Medicine, Wroclaw Medical University, Pasteura 1, Wroclaw, 50-367, Poland.
Cell communication and signaling : CCS
|October 10, 2024
概括
癌细胞由于瘤微环境 (TME) 相互作用而抵抗药物. 在TME内部的细胞外囊泡 (EVs) 通过运输信号分子和药物排放,在化学抵抗中发挥关键作用.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 化学抵抗是癌症治疗的一个重要障碍.
- 瘤微环境 (TME) 和细胞-细胞通信越来越多地被认为是化学抵抗的关键因素.
- 关键的TME组成部分包括癌细胞,介质干细胞,纤维细胞,树突细胞和巨细胞.
研究的目的:
- 探索瘤微环境 (TME) 和细胞间通信在抗化学药物的发展中的作用.
- 研究TME成分对癌细胞药物耐药性的特定机制.
主要方法:
- 关于瘤微环境和化学抵抗的当前文献的综述.
- 细胞间通信通路的分析,包括直接和间接的相互作用.
- 专注于细胞外囊泡 (EVs) 在调解化学抵抗中的作用.
主要成果:
- 在TME内部的细胞间通信对于化学抵抗的发展至关重要.
- 细胞外囊泡 (EVs) 是重要的媒介体,运输脂质,蛋白质和核酸.
- 电动汽车可以传输药物排放,增强癌细胞的抵抗力.
结论:
- TME及其通信网络对于理解和克服化学阻力至关重要.
- 针对EV介导的沟通是对抗耐药癌症的潜在治疗策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


